Comparison of Two Hysteroscopy Approaches

Status Completed

Clinical Trial Summary

This randomized clinical trial compares two methods of diagnostic hysteroscopy: vaginoscopic hysteroscopy vs. traditional method. Pain intensity was estimated using a visual analogue scale (VAS), and patient satisfaction was evaluated. These endpoints were compared by treatment assignment. Vaginoscopic hysteroscopy was associated with significantly lower VAS scores, indicating reduced experience of pain in this treatment group; however, this was not associated with improved patient satisfaction.

Clinical Trial Description

OBJECTIVE: To compare the vaginoscopic approach of diagnostic hysteroscopy without anesthesia with the traditional diagnostic hysteroscopy after intracervical injection of Mepivacaine Hydrochloride 3%.

METHODS: A total of 130 women undergoing diagnostic hysteroscopy were included in the study and were randomized, using a computer-generated randomization list, into two groups with a ratio of 2:1. Eighty three women underwent vaginoscopy without speculum, tenaculum or anesthesia. Forty seven women received intracervical anesthesia with 10 ml of 3% mepivacaine hydrochloride solution injected at two sites (3:00 and 9:00 positions) and underwent traditional hysteroscopy using a speculum and tenaculum. Hysteroscopy was performed using a rigid 3.7 mm hysteroscope in a medium of 0.9% saline, and the image was transmitted to a screen visible to the patient. A Visual Scale Analogue (VAS) consisting of a 10 cm line was used to assess the intensity of pain experienced during and after the procedure. Overall patient satisfaction was assessed during, immediately after, 15 minutes later, and three days post hysteroscopy.

RESULTS: The mean pain score was significantly lower in the vaginoscopy group (3.8±2.7 vs 5.34±3.23, p=0.01). Patient satisfaction rate was similar in both groups.

CONCLUSION: Patients reported significantly less pain with the vaginoscopic approach to diagnostic hysteroscopy even without anesthesia compared to patients undergoing the traditional procedure with anesthesia. This new approach should therefore be considered as a replacement for the traditional hysteroscopic technique. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Menorrhagia

Clinical Trial Details

NCT number	NCT00319410
Study type	Interventional
Source	Wolfson Medical Center
Contact
Status	Completed
Phase	Phase 3
Start date	July 2005
Completion date	December 2005

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02824224` - Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)	Phase 4
Withdrawn	`NCT01651468` - The Effect of the Nutraceutical "Hemofix" on the Coagulation System	N/A
Recruiting	`NCT02616731` - Oral Tranexamic Acid Versus Diosmin for Treatment of Menorrhagia in Women Using Copper IUD	Phase 1/Phase 2
Terminated	`NCT02087228` - Evaluation of the Endometrial Cavity After Endometrial Ablation	N/A
Withdrawn	`NCT00953641` - Vaginal Misoprostol for Cervical Ripening Prior to Endometrial Biopsy	Phase 3
Completed	`NCT01436903` - Chances for Success of CavatermTM Surgery as a Function of Uterus Probe Length	Phase 4
Withdrawn	`NCT00768742` - Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study	N/A
Completed	`NCT00152256` - A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids	Phase 3
Completed	`NCT00156195` - Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids	Phase 3
Completed	`NCT00160381` - A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids	Phase 3
Completed	`NCT02228174` - Sonography Guided Transcervical Ablation of Uterine Fibroids	N/A
Terminated	`NCT01969396` - Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology	N/A
Completed	`NCT00386308` - Efficacy and Safety Study of XP12B in Women With Menorrhagia	Phase 3
Completed	`NCT00393198` - Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia	Phase 4
Completed	`NCT00966264` - Hysterectomy and Levonorgestrel Releasing Intrauterine System (LNG-IUS) in the Treatment of Menorrhagia	Phase 3
Completed	`NCT00904709` - The Assessment of Tranexamic Acid in Women With Menorrhagia Who Have Bleeding Disorders	Phase 4
Recruiting	`NCT03670680` - Efficiency of Lina LibrataTM System	N/A
Completed	`NCT02584088` - Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation
Completed	`NCT02835391` - PerClot Compared to Usual Care in Gynaecology Procedures	N/A
Completed	`NCT02304510` - Prevalence of Heavy Menstrual Bleeding in Female Population Living in Beijing

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.